Next-generation sequencing and protein mass spectrometry for the comprehensive analysis of human cellular and serum antibody repertoires

Current Opinion in Chemical Biology

Volumn 24, Issue , 2015, Pages 112-120

  Lavinder, Jason J ^a,b   Horton, Andrew P ^a,b   Georgiou, George ^a,b   Ippolito, Gregory C ^b  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; B LYMPHOCYTE ANTIBODY; B LYMPHOCYTE ANTIGEN; CELL ANTIBODY; IMMUNOGLOBULIN; VACCINE; VON HIPPEL LINDAU PROTEIN; ANTIBODY;

AMINO ACID SEQUENCE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; AUTOIMMUNITY; B LYMPHOCYTE; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION; MASS SPECTROMETRY; MOLECULAR SIZE; NEOPLASM; NONHUMAN; PROTEIN ANALYSIS; PROTEOMICS; REVIEW; SEROLOGY; SPECIES DIVERSITY; STEADY STATE; TUMOR IMMUNITY; BLOOD; CHEMISTRY; GENETICS; GENOMICS; IMMUNOLOGY; METABOLISM; PROCEDURES;

ANTIBODIES; B-LYMPHOCYTES; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MASS SPECTROMETRY; PROTEOMICS;

EID: 84911909440     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2014.11.007     Document Type: Review

References (76)

1. Lavinder J.J., Wine Y., Giesecke C., Ippolito G.C., Horton A.P., Lungu O.I., Hoi K.H., DeKosky B.J., Murrin E.M., Wirth M.M., et al. Identification and characterization of the constituent human serum antibodies elicited by vaccination. Proc Natl Acad Sci U S A 2014, 111:2259-2264.
2. Wine Y., Boutz D.R., Lavinder J.J., Miklos A.E., Hughes R.A., Hoi K.H., Jung S.T., Horton A.P., Murrin E.M., Ellington A.D., et al. Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response. Proc Natl Acad Sci U S A 2013, 110:2993-2998.
3. Boutz D.R., Horton A.P., Wine Y., Lavinder J.J., Georgiou G., Marcotte E.M. Proteomic identification of monoclonal antibodies from serum. Anal Chem 2014, 86:4758-4766.
4. Cheung W.C., Beausoleil S.A., Zhang X.W., Sato S., Schieferl S.M., Wieler J.S., Beaudet J.G., Ramenani R.K., Popova L., Comb M.J., et al. A proteomics approach for the identification and cloning of monoclonal antibodies from serum. Nat Biotechnol 2012, 30:447.
5. Sato S., Beausoleil S.A., Popova L., Beaudet J.G., Ramenani R.K., Zhang X.W., Wieler J.S., Schieferl S.M., Cheung W.C., Polakiewicz R.D. Proteomics-directed cloning of circulating antiviral human monoclonal antibodies. Nat Biotechnol 2012, 30:1039-1043.
6. Georgiou G., Ippolito G.C., Beausang J., Busse C.E., Wardemann H., Quake S.R. The promise and challenge of high-throughput sequencing of the antibody repertoire. Nat Biotechnol 2014, 32:158-168.
7. Mathonet P., Ullman C.G. The application of next generation sequencing to the understanding of antibody repertoires. Front Immunol 2013, 4:265.
8. DeKosky B.J., Ippolito G.C., Deschner R.P., Lavinder J.J., Wine Y., Rawlings B.M., Varadarajan N., Giesecke C., Dorner T., Andrews S.F., et al. High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire. Nat Biotechnol 2013, 31:166-169.
9. Tan Y.C., Blum L.K., Kongpachith S., Ju C.H., Cai X., Lindstrom T.M., Sokolove J., Robinson W.H. High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination. Clin Immunol 2014, 151:55-65.
10. Lu D.R., Tan Y.C., Kongpachith S., Cai X.Y., Stein E.A., Lindstrom T.M., Sokolove J., Robinson W.H. Identifying functional anti-Staphylococcus aureus antibodies by sequencing antibody repertoires of patient plasmablasts. Clin Immunol 2014, 152:77-89.
11. Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996, 381:751-758.
12. Tarlinton D., Good-Jacobson K. Diversity among memory B cells: origin, consequences, and utility. Science 2013, 341:1205-1211.
13. Slifka M.K., Ahmed R. Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity. Trends Microbiol 1996, 4:394-400.
14. Klinman N.R., Press J.L. Characterization of B-cell repertoire specific for 2,4-dinitrophenyl and 2,4,6-trinitrophenyl determinants in neonatal balb-c mice. J Exp Med 1975, 141:1133-1146.
15. Arnaout R., Lee W., Cahill P., Honan T., Sparrow T., Weiand M., Nusbaum C., Rajewsky K., Koralov S.B. High-resolution description of antibody heavy-chain repertoires in humans. PLoS ONE 2011, 6:e22365.
16. Vollmers C., Sit R.V., Weinstein J.A., Dekker C.L., Quake S.R. Genetic measurement of memory B-cell recall using antibody repertoire sequencing. Proc Natl Acad Sci U S A 2013, 110:13463-13468.
17. Glanville J., Kuo T.C., von Budingen H.C., Guey L., Berka J., Sundar P.D., Huerta G., Mehta G.R., Oksenberg J.R., Hauser S.L., et al. Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation. Proc Natl Acad Sci U S A 2011, 108:20066-20071.
18. Boyd S.D., Marshall E.L., Merker J.D., Maniar J.M., Zhang L.N., Sahaf B., Jones C.D., Simen B.B., Hanczaruk B., Nguyen K.D., et al. Measurement and clinical monitoring of human lymphocyte clonality by massively parallel V-D-J pyrosequencing. Sci Transl Med 2009, 1:12ra23.
19. Laserson U., Vigneault F., Gadala-Maria D., Yaari G., Uduman M., Vander Heiden J.A., Kelton W., Taek Jung S., Liu Y., Laserson J., et al. High-resolution antibody dynamics of vaccine-induced immune responses. Proc Natl Acad Sci U S A 2014, 111:4928-4933.
20. Ippolito G.C., Hoi K.H., Reddy S.T., Carroll S.M., Ge X., Rogosch T., Zemlin M., Shultz L.D., Ellington A.D., VanDenBerg C.L., et al. Antibody repertoires in humanized NOD-SCID-IL2R gamma(null) mice and human B cells reveals human-like diversification and tolerance checkpoints in the mouse. PLoS ONE 2012, 7:e35497.
21. Larimore K., McCormick M.W., Robins H.S., Greenberg P.D. Shaping of human germline IgH repertoires revealed by deep sequencing. J Immunol 2012, 189:3221-3230.
22. Benichou J., Glanville J., Prak E.T.L., Azran R., Kuo T.C., Pons J., Desmarais C., Tsaban L., Louzoun Y. The restricted D-H gene reading frame usage in the expressed human antibody repertoire is selected based upon its amino acid content. J Immunol 2013, 190:5567-5577.
23. Ippolito G.C., Schelonka R.L., Zemlin M., Ivanov I.I., Kobayashi R., Zemlin C., Gartland G.L., Nitschke L., Pelkonen J., Fujihashi K., et al. Forced usage of positively charged amino acids in immunoglobulin CDR-H3 impairs B cell development and antibody production. J Exp Med 2006, 203:1567-1578.
24. Trad A., Tanasa R.I., Lange H., Zemlin M., Schroeder H.W., Lemke H. Clonal progression during the T cell-dependent B cell antibody response depends on the immunoglobulin DH gene segment repertoire. Front Immunol 2014, 5:385.
25. Purtha W.E., Tedder T.F., Johnson S., Bhattacharya D., Diamond M.S. Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants. J Exp Med 2011, 208:2599-2606.
26. Foote J., Eisen H.N. Kinetic and affinity limits on antibodies produced during immune-responses. Proc Natl Acad Sci U S A 1995, 92:1254-1256.
27. Langman R.E., Cohn M. The E-T (elephant-tadpole) paradox necessitates the concept of a unit of B-cell function-the protecton. Mol Immunol 1987, 24:675-697.
28. Plotkin S.A. Correlates of vaccine-induced immunity. Clin Infect Dis 2008, 47:401-409.
29. Jackson K.J.L., Liu Y., Roskin K.M., Glanville J., Hoh R.A., Seo K., Marshall E.L., Gurley T.C., Moody M.A., Haynes B.F., et al. Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. Cell Host Microbe 2014, 16:105-114.
30. Jiang N., He J.K., Weinstein J.A., Penland L., Sasaki S., He X.S., Dekker C.L., Zheng N.Y., Huang M., Sullivan M., et al. Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci Transl Med 2013, 5:171ra19.
31. Wu Y.C., Kipling D., Dunn-Walters D.K. Age-related changes in human peripheral blood IgH repertoire following vaccination. Front Immunol 2012, 3:193.
32. Ademokun A., Wu Y.-C., Martin V., Mitra R., Sack U., Baxendale H., Kipling D., Dunn-Walters D.K. Vaccination-induced changes in human B-cell repertoire and pneumococcal IgM and IgA antibody at different ages. Aging Cell 2011, 10:922-930.
33. Gibson K.L., Wu Y.C., Barnett Y., Duggan O., Vaughan R., Kondeatis E., Nilsson B.O., Wikby A., Kipling D., Dunn-Walters D.K. B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 2009, 8:18-25.
34. Guerrettaz L.M., Johnson S.A., Cambier J.C. Acquired hematopoietic stem cell defects determine B-cell repertoire changes associated with aging. Proc Natl Acad Sci U S A 2008, 105:11898-11902.
35. Wang C., Liu Y., Xu L.T., Jackson K.J.L., Roskin K.M., Pham T.D., Laserson J., Marshall E.L., Seo K., Lee J.Y., et al. Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoires. J Immunol 2014, 192:603-611.
36. Frolich D., Giesecke C., Mei H.E., Reiter K., Daridon C., Lipsky P.E., Dorner T. Secondary immunization generates clonally related antigen-specific plasma cells and memory B cells. J Immunol 2010, 185:3103-3110.
37. Giesecke C., Frolich D., Reiter K., Mei H.E., Wirries I., Kuhly R., Killig M., Glatzer T., Stolzel K., Perka C., et al. Tissue distribution and dependence of responsiveness of human antigen-specific memory B cells. J Immunol 2014, 192:3091-3100.
38. Obermoser G., Presnell S., Domico K., Xu H., Wang Y.Y., Anguiano E., Thompson-Snipes L., Ranganathan R., Zeitner B., Bjork A., et al. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 2013, 38:831-844.
39. Tsang J.S., Schwartzberg P.L., Kotliarov Y., Biancotto A., Xie Z., Germain R.N., Wang E., Olnes M.J., Narayanan M., Golding H., et al. Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell 2014, 157:499-513.
40. Pulendran B. Systems vaccinology: probing humanity's diverse immune systems with vaccines. Proc Natl Acad Sci U S A 2014, 111:12300-12306.
41. DeKosky B.J., Kojima T., Rodin A., Charab W., Ippolito G.C., Ellington A.D., Georgiou G. Ultra-high throughput antibody VH:VL sequencing using a novel single-cell flow focusing technology. Nat Med 2014, (in press).
42. Fink K. Origin and function of circulating plasmablasts during acute viral infections. Front Immunol 2012, 3:78.
43. Hofer T., Muehlinghaus G., Moser K., Yoshida T.H.E.M., Hebel K., Hauser A., Hoyer B.E.O.L., Dorner T., et al. Adaptation of humoral memory. Immunol Rev 2006, 211:295-302.
44. Franz B., May K.F., Dranoff G., Wucherpfennig K. Ex vivo characterization and isolation of rare memory B cells with antigen tetramers. Blood 2011, 118:348-357.
45. Parameswaran P., Liu Y., Roskin K.M., Jackson K.K., Dixit V.P., Lee J.Y., Artiles K.L., Zompi S., Vargas M.J., Simen B.B., et al. Convergent antibody signatures in human dengue. Cell Host Microbe 2013, 13:691-700.
46. Kodadek T. Chemical tools to monitor and manipulate the adaptive immune system. Chem Biol 2014, 21:1066-1074.
47. Wrammert J., Smith K., Miller J., Langley W.A., Kokko K., Larsen C., Zheng N.Y., Mays I., Garman L., Helms C., et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453. 667-U610.
48. Kwong P.D., Mascola J.R. Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies. Immunity 2012, 37:412-425.
49. Corti D., Lanzavecchia A. Broadly neutralizing antiviral antibodies. Annu Rev Immunol 2013, 31:705-742.
50. Liao H.X., Lynch R., Zhou T., Gao F., Alam S.M., Boyd S.D., Fire A.Z., Roskin K.M., Schramm C.A., Zhang Z., et al. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 2013, 496:469-476.
51. Wu X., Zhou T., Zhu J., Zhang B., Georgiev I., Wang C., Chen X., Longo N.S., Louder M., McKee K., et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 2011, 333:1593-1602.
52. Zhu J., O'Dell S., Ofek G., Pancera M., Wu X., Zhang B., Zhang Z., Mullikin J.C., Simek M., Burton D.R., et al. Somatic populations of PGT135-137 HIV-1-neutralizing antibodies identified by 454 pyrosequencing and bioinformatics. Front Microbiol 2012, 3:315.
53. Zhu J., Wu X., Zhang B., McKee K., O'Dell S., Soto C., Zhou T., Casazza J.P., Mullikin J.C., Kwong P.D., et al. De novo identification of VRC01 class HIV-1-neutralizing antibodies by next-generation sequencing of B-cell transcripts. Proc Natl Acad Sci U S A 2013, 110:E4088-E4097.
54. Zhu J., Ofek G., Yang Y.P., Zhang B.S., Louder M.K., Lu G., McKee K., Pancera M., Skinner J., Zhang Z.H., et al. Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains. Proc Natl Acad Sci U S A 2013, 110:6470-6475.
55. Gao F., Bonsignori M., Liao H.X., Kumar A., Xia S.M., Lu X.Z., Cai F.P., Hwang K.K., Song H.S., Zhou T.Q., et al. Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies. Cell 2014, 158:481-491.
56. Stern J.N.H., Yaari G., Vander Heiden J.A., Church G., Donahue W.F., Hintzen R.Q., Huttner A.J., Laman J.D., Nagra R.M., Nylander A., et al. B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes. Sci Transl Med 2014, 6.
57. Palanichamy A., Apeltsin L., Kuo T.C., Sirota M., Wang S.Z., Pitts S.J., Sundar P.D., Telman D., Zhao L.Z., Derstine M., et al. Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis. Sci Transl Med 2014, 6.
58. Doorenspleet M.E., Klarenbeek P.L., de Hair M.J., van Schaik B.D., Esveldt R.E., van Kampen A.H., Gerlag D.M., Musters A., Baas F., Tak P.P., et al. Rheumatoid arthritis synovial tissue harbours dominant B-cell and plasma-cell clones associated with autoreactivity. Ann Rheum Dis 2014, 73:756-762.
59. Thurgood L.A., Arentz G., Lindop R., Jackson M.W., Whyte A.F., Colella A.D., Chataway T.K., Gordon T.P. An immunodominant La/SSB autoantibody proteome derives from public clonotypes. Clin Exp Immunol 2013, 174:237-244.
60. Lindop R., Arentz G., Chataway T.K., Thurgood L.A., Jackson M.W., Reed J.H., McCluskey J., Gordon T.P. Molecular signature of a public clonotypic autoantibody in primary Sjogren's syndrome: a forbidden clone in systemic autoimmunity. Arthritis Rheum 2011, 63:3477-3486.
61. Arentz G., Thurgood L.A., Lindop R., Chataway T.K., Gordon T.P. Secreted human Ro52 autoantibody proteomes express a restricted set of public clonotypes. J Autoimmun 2012, 39:466-470.
62. Murphy M.A., O'Leary J.J., Cahill D.J. Assessment of the humoral immune response to cancer. J Proteomics 2012, 75:4573-4579.
63. Barnidge D.R., Tschumper R.C., Theis J.D., Snyder M.R., Jelinek D.F., Katzmann J.A., Dispenzieri A., Murray D.L. Monitoring M-proteins in patients with multiple myeloma using heavy-chain variable region clonotypic peptides and LC-MS/MS. J Proteome Res 2014, 13:1905-1910.
64. He J., Wu J., Jiao Y., Wagner-Johnston N., Ambinder R.F., Diaz L.A., Kinzler K.W., Vogelstein B., Papadopoulos N. IgH gene rearrangements as plasma biomarkers in Non-Hodgkin's lymphoma patients. Oncotarget 2011, 2:178-185.
65. Faham M., Zheng J., Moorhead M., Carlton V.E., Stow P., Coustan-Smith E., Pui C.H., Campana D. Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia. Blood 2012, 120:5173-5180.
66. Gawad C., Pepin F., Carlton V.E., Klinger M., Logan A.C., Miklos D.B., Faham M., Dahl G., Lacayo N. Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia. Blood 2012, 120:4407-4417.
67. Logan A.C., Gao H., Wang C., Sahaf B., Jones C.D., Marshall E.L., Buno I., Armstrong R., Fire A.Z., Weinberg K.I., et al. High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment. Proc Natl Acad Sci U S A 2011, 108:21194-21199.
68. Wu D., Emerson R.O., Sherwood A., Loh M.L., Angiolillo A., Howie B., Vogt J., Rieder M., Kirsch I., Carlson C., et al. Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH. Clin Cancer Res 2014, 20:4540-4548.
69. Tschumper R.C., Asmann Y.W., Hossain A., Huddleston P.M., Wu X., Dispenzieri A., Eckloff B.W., Jelinek D.F. Comprehensive assessment of potential multiple myeloma immunoglobulin heavy chain V-D-J intraclonal variation using massively parallel pyrosequencing. Oncotarget 2012, 3:502-513.
70. Ladetto M., Bruggemann M., Monitillo L., Ferrero S., Pepin F., Drandi D., Barbero D., Palumbo A., Passera R., Boccadoro M., et al. Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders. Leukemia 2014, 28:1299-1307.
71. Galson J.D., Pollard A.J., Truck J., Kelly D.F. Studying the antibody repertoire after vaccination: practical applications. Trends Immunol 2014, 35:319-331.
72. Calis J.J., Rosenberg B.R. Characterizing immune repertoires by high throughput sequencing: strategies and applications. Trends Immunol 2014, (Epub ahead of print).
73. Mattoo H., Mahajan V.S., Della-Torre E., Sekigami Y., Carruthers M., Wallace Z.S., Deshpande V., Stone J.H., Pillai S. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol 2014, 134:679-687.
74. Srivastava R., Aslam M., Kalluri S.R., Schirmer L., Buck D., Tackenberg B., Rothhammer V., Chan A., Gold R., Berthele A., et al. Potassium channel KIR4.1 as an immune target in multiple sclerosis. N Engl J Med 2012, 367:115-123.
75. Reardon D.A., Freeman G., Wu C., Chiocca E.A., Wucherpfennig K.W., Wen P.Y., Fritsch E.F., Curry W.T., Sampson J.H., Dranoff G. Immunotherapy advances for glioblastoma. Neuro Oncol 2014, 16:1441-1458.
76. World Health Organization (WHO) Use of Convalescent Whole Blood or Plasma Collected From Patients Recovered from Ebola Virus Disease for Transfusion, as an Empirical Treatment during Outbreaks 2014, WHO/HIS/SDS/2014.8.